Description
GALLIUM GA68 TREATMENT
First action · last action
2023-05-01 · 2024-01-05
Transactions
5
First transaction's obligation
$87,000
Base + all options value (sum of deltas)
$277,315
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-05-01+$87,000= $87,000
- Mod P000012023-09-11+$98,600= $185,600
- Mod P000022023-09-29+$113,100= $298,700
- Mod P000032024-01-05-$11,353= $287,348
- Mod P000042024-01-05-$10,033= $277,315
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-05-01 | +$87,000 | $87,000 | GALLIUM GA68 TREATMENT |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-09-11 | +$98,600 | $185,600 | GALLIUM GA68 TREATMENT |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-09-29 | +$113,100 | $298,700 | GALLIUM GA68 TREATMENT |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-05 | −$11,353 | $287,348 | GALLIUM GA68 TREATMENT |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-05 | −$10,033 | $277,315 | GALLIUM GA68 TREATMENT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZL79MXYVNDM1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24726P0672 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $112,908 | FY2026 |
| 36C25926N0360 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $151,197 | FY2026 |
| 36C25926D0048 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C26026N0258 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $122,387 | FY2026 |
| 36C24426N0682 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $590,927 | FY2026 |
| 36C25026N0520 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $310,000 | FY2026 |
Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0367 | ISORX TEXAS LTD | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $53,945 | FY2026 |
| 36C25726N0407 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,400,000 | FY2026 |
| 36C25726P0476 | PETNET SOLUTIONS, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,573 | FY2026 |
| 36C25726P0423 | PANHANDLE NUCLEAR RX, LTD. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $325,038 | FY2026 |
| 36C25726N0316 | PROGENICS PHARMACEUTICALS INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $721,744 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25723P0306_3600_-NONE-_-NONE- · retrieved 2026-09-26.